Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Hc Mwandumba"'
Autor:
E Chinyama, Kc Jambo, Ben Morton, Raphael Kamng'ona, Grace Katha, O Kanjewa, S Sichone, C Ntwea, D Tembo, B Denis, E Nsomba, A Chingota, S Kaimba, Kelvin Mponda, M Mkandawire, E Storey, James Jafali, Clinical, Catherine Anscombe, Jennifer E. Cornick, S Lissauer, V Nyasulu, H Thole, J Phulusa, Chimota Phiri, Khuzwayo C. Jere, Ndaziona Peter Banda, P Mwenechanya, M Chaponda, L Mvaya, James Nyirenda, Sb Gordon, J Gondwe, Ks Mndolo, P Kambiya, V Kaudzu, Pi Iroh Tam, C Van Der Veer, Myr Henrion, P Mandala, C Mhango, S Nthala, Jane Mallewa, Td Swarthout, Tamara Phiri, P MacPherson, B Chinoko, B Freyne, Jamie Rylance, A Lakudzala, Jonathan Mandolo, A Ahmadu, Prisca Matambo, C Masesa, Comfort Brown, D Matchado, J Chirombo, Kg Barnes, N Bondera, A Zuza, M Gmeiner, A Chande, Hc Mwandumba, L Keyala
Publikováno v:
Nature Communications
medRxiv
article-version (status) pre
article-version (number) 2
medRxiv
article-version (status) pre
article-version (number) 2
Although the COVID-19 pandemic has left no country untouched there has been limited research to understand clinical and immunological responses in African populations. Here we characterise patients hospitalised with suspected (PCR-negative/IgG-positi
Publikováno v:
Gut. 64:A400.2-A401
Introduction Rates of upper gastrointestinal pathology requiring diagnostic and therapeutic intervention in Southern Malawi are high, resources and endoscopy services are limited, and there are very few independently practicing endoscopists. Endoscop
Autor:
Rose Malamba, HC Mwandumba, N Mtunthama, M Feeney, M Hendrickse, P O’Toole, J Geraghty, Melita A. Gordon, A Kankwatira, L Kalongolera
Publikováno v:
Gut. 61:A12.2-A12
Introduction Sustainable endoscopy services could improve management of upper gastrointestinal malignancy and haemorrhage, both common in Malawi. Since 2008 we have committed to improving endoscopy training through an International Health Link (IHL)
Autor:
Stott KE; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Mohabir JT; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Bowers K; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Tenor JL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Toffaletti DL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Ahmadu A; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Moyo M; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi., Gondwe E; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Chimang'anga W; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Chasweka M; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Tropical Medicine, London, United Kingdom.; Botswana Harvard Health Partnership, Gaborone, Botswana.; Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Tropical Medicine, London, United Kingdom.; Botswana Harvard Health Partnership, Gaborone, Botswana., Harrison T; Institute of Infection and Immunity, St George's University London, London, United Kingdom., Hope W; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Mwandumba HC; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Perfect JR; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Cuomo CA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Publikováno v:
MBio [mBio] 2024 Oct 16; Vol. 15 (10), pp. e0159224. Date of Electronic Publication: 2024 Aug 27.
Autor:
Rickman HM; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Malawi Liverpool Wellcome Programme, Blantyre, Malawi., Phiri MD; Malawi Liverpool Wellcome Programme, Blantyre, Malawi.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Feasey HRA; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Malawi Liverpool Wellcome Programme, Blantyre, Malawi., Mbale H; Malawi Liverpool Wellcome Programme, Blantyre, Malawi., Nliwasa M; Helse Nord TB Initiative, Kamuzu University of Health Sciences, Blantyre, Malawi., Semphere R; Helse Nord TB Initiative, Kamuzu University of Health Sciences, Blantyre, Malawi.; School of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom., Chagaluka G; Department of Paediatrics, Queen Elizabeth Central Hospital, Blantyre, Malawi., Fielding K; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom., Mwandumba HC; Malawi Liverpool Wellcome Programme, Blantyre, Malawi.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Horton KC; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom., Nightingale ES; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom., Henrion MYR; Malawi Liverpool Wellcome Programme, Blantyre, Malawi.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Mbendera K; Malawi National Tuberculosis and Leprosy Control Programme, Lilongwe, Malawi., Mpunga JA; Malawi National Tuberculosis and Leprosy Control Programme, Lilongwe, Malawi., Corbett EL; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Malawi Liverpool Wellcome Programme, Blantyre, Malawi., MacPherson P; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Malawi Liverpool Wellcome Programme, Blantyre, Malawi.; School of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2024 May 24; Vol. 19 (5), pp. e0291215. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).
Autor:
Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana. Electronic address: joseph.jarvis@lshtm.ac.uk., Chou R; Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland, OR, USA., Harrison TS; Institute of Infection and Immunity, St George's University London, London, UK; The Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Muthoga C; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland., Mupeli K; The Center for Youth of Hope, Gaborone, Botswana., Meya DB; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Mwandumba HC; Liverpool School of Tropical Medicine, Liverpool, UK; Malawi-Liverpool-Wellcome Clinical Research Programme, Blantyre, Malawi., Kanyama C; Lilongwe Medical Relief Trust, University of North Carolina Project, Lilongwe, Malawi., Meintjes G; The Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa., Leeme TB; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Ndhlovu CE; Internal Medicine Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Beattie P; European & Developing Countries Clinical Trials Partnership, Hague, Netherlands., Sued O; Pan American Health Organization, Washington, DC, USA., Pérez Casas C; Unitaid, Geneva, Switzerland., Makanga M; European & Developing Countries Clinical Trials Partnership, Hague, Netherlands., Ford N; Department of Global HIV, Viral Hepatitis and Sexually Transmitted Infections Programmes, WHO, Geneva, Switzerland.
Publikováno v:
The Lancet. Global health [Lancet Glob Health] 2023 Nov; Vol. 11 (11), pp. e1688-e1690.
Autor:
Gordon SB; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK., Sichone S; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Chirwa AE; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Hazenberg P; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK., Kafuko Z; 1Day Africa, 1Day Sooner, Lusaka Province, Zambia., Ferreira DM; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.; Oxford Vaccine Group, University of Oxford, Oxford, UK., Flynn J; Centre for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Fortune S; Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA., Balasingam S; Wellcome Trust, London, UK., Biagini GA; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK., McShane H; The Jenner Institute, University of Oxford, Oxford, UK., Mwandumba HC; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK., Jambo K; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK., Dedha K; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.; Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK., Raj Sharma N; Wellcome Trust, London, UK., Robertson BD; Imperial College London, London, UK., Walker NF; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK., Morton B; Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Publikováno v:
Wellcome open research [Wellcome Open Res] 2023 Jun 12; Vol. 8, pp. 71. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023).
Autor:
Stott KE; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Ahmadu A; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Kajanga C; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Moyo M; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi., Gondwe E; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Chimang'anga W; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Chasweka M; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Jagota B; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Shah RV; Institute for Infection and Immunity, St George's University London, London, UK., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, UK., Harrison T; Clinical Academic Group in Infection, St George's University Hospitals NHS Foundation Trust, London, UK.; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Mwandumba HC; Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2023 Apr 03; Vol. 78 (4), pp. 1015-1022.
Autor:
Harrison TS; Institute of Infection and Immunity, St George's University London, London, United Kingdom.; Clinical Academic Group in Infection and Immunity, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Mwandumba HC; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Malawi-Liverpool-Wellcome Clinical Research Programme, Blantyre, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi., Boulware DR; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Hosseinipour MC; Lilongwe Medical Relief Trust (University of North Carolina Project), Lilongwe, Malawi.; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA., Lortholary O; Institut Pasteur, National Center for Scientific Research, Molecular Mycology Unit and National Reference Center for Invasive Mycoses and Antifungals, Unités Mixtes de Recherche 2000, Paris, France.; Université de Paris-Cité, Necker Pasteur Center for Infectious Diseases and Tropical Medicine, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris, IHU Imagine, Paris, France., Meintjes G; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa.; Department of Medicine, University of Cape Town, Cape Town, South Africa., Mosepele M; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Internal Medicine, University of Botswana, Gaborone, Botswana., Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Mar 04; Vol. 76 (5), pp. 944-949.
Autor:
Stott KE; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK.; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Moyo M; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Malawi., Ahmadu A; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Kajanga C; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Gondwe E; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Chimang'anga W; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Chasweka M; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi., Leeme TB; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana., Molefi M; University of Botswana, Gaborone, Botswana., Chofle A; National Institute of Medical Research, Mwanza, Tanzania., Bidwell G; National Institute of Medical Research, Mwanza, Tanzania., Changalucha J; National Institute of Medical Research, Mwanza, Tanzania., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Mwandumba HC; Malawi Liverpool Wellcome Programme, Kamuzu University of Health Sciences, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Malawi.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, UK., Harrison TS; Institute of Infection and Immunity, St George's University Hospital, London, UK.; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK., Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK., Märtson AG; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, University of Liverpool, UK.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Dec 23; Vol. 78 (1), pp. 276-283.